B-ENT
Timing of Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss
Background: To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL), with particular emphasis on the impact of treatment initiation timing. Methods: This retrospective study included 127 patients with ISSNHL who received HBOT at the Ankara Etlik City Hospital, between February 2023 and August 2024. Patients were categorized into 3 groups based on treatment initiation time: Group 1 (0-14 days), Group 2 (15-30 days), and Group 3 (>30 days) …